Johnnie Orozco, MD, Oncology, Seattle, WA, Seattle Cancer Care Alliance

JohnnieJoseOrozcoMD

Oncology Seattle, WA

Hematologic Oncology

Assistant Professor

Dr. Orozco is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Orozco's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFELLOWSHIP
  • UCSF
    UCSFRESIDENCY
  • University of Washington School of Medicine
    University of Washington School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2009 - 2022
  • CA State Medical License
    CA State Medical License 2008 - Present
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) ...
    Johnnie Orozco, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) ...
    Johnnie Orozco, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • The Alpha Emitter Astatine-211 Targeted to CD38 Can Eradicate Multiple Myeloma in Minimal Residual Disease Models 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • A Phase 2 Study of Actinium-225 (225Ac)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 µci/Kg/Dose 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • $3.4 Million Grant to Find Safer, More Effective Leukemia Treatments
    $3.4 Million Grant to Find Safer, More Effective Leukemia TreatmentsJuly 27, 2020

Professional Memberships

Hospital Affiliations